Skip to main content

Intelligent Live Cell Analysis [iLCA] to transform disease management through faster, and more regulatory robust, discovery, manufacture and monitoring of biologic drugs & cell therapies

Deliverables

Peer reviewed publication submitted

Publish papers on case studies, applications and value propositions that have used and benefited from the use of the iLCA platform. Peer reviewed publication submitted for consideration to Biotechnology and Bioprocess Engineering to be made available through Gold Open Access (Month 23).